Skin manifestations of cushing disease in children and adolescents before and after the resolution of hypercortisolemia

Pediatric Dermatology

Volumn 15, Issue 4, 1998, Pages 253-258

  Stratakis, Constantine A ^a,c   Mastorakos, George ^b   Mitsiades, Nicholas S ^a   Mitsiades, Constantine S ^a   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c SPE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ARTICLE; CAPILLARY RESISTANCE; CHILD; CLINICAL ARTICLE; CUSHING DISEASE; FEMALE; HIRSUTISM; HORMONE DETERMINATION; HUMAN; HYPERCORTISOLISM; HYPERPIGMENTATION; INSULIN RESISTANCE; MALE; MYCOSIS; PRIORITY JOURNAL; REMISSION; SKIN DISEASE; SKIN MANIFESTATION; ZONA FASCICULATA;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CUSHING SYNDROME; FEMALE; HUMANS; HYDROCORTISONE; INCIDENCE; MALE; POSTOPERATIVE PERIOD; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN DISEASES; TIME FACTORS;

EID: 0031830362     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.1998.1998015253.x     Document Type: Article

References (30)

1. Chrousos GP, Loriaux DL. Cushing's syndrome. In: Rakel RE, ed. Conn's current therapy. Philadelphia: WB Saunders, 1987:495-498.
2. Stratakis CA, Chrousos GP. Ch 260: Cushing syndrome and disease. In: Finberg L. ed. Saunder's manual of pediatric practice. Philadelphia: WB Saunders, 1998:807-809.
3. Magiakou MA, Mastorakos G, Oldfield EH, et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis, therapy. N Engl J Med 1994;331:629-636.
4. Stratakis CA, Chrousos GP. Endocrine tumors. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology, 3rd ed. Philadelphia: JB Lippincott, 1997:947-976.
5. Thiboutot DM. Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab 1995;80:3082-3087.
6. Matsuoka LY, Wortsman J, Goldman J. Acanthosis nigricans. Clin Dermatol 1993;11:21-25.
7. Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci 1995;771:1-18.
8. Feingold KR, Elias PM. Endocrine-skin interactions: cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders and diabetes. J Am Acad Dermatol, 1987;17:921-940.
9. Liddle GW. Tests of pituitary adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1960;20:1539-1560.
10. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB Jr, Loriaux DL. The corticotropin-releasing factor stimulation test: an aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 1984;310:622-626.
11. Nieman LK, Cutler GB Jr, Oldfield EH, Loriaux DL, Chrousos GP. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. J Clin Endocrinol Metab 1989;150:99-103.
12. Franks RC. Urinary 17-hydroxycorticosteroid and cortisol excretion in childhood. J Clin Endocrinol Metab 1973;36: 702-705.
13. Gomez MT, Malozowski S, Winterer J, Vamvakopoulos NC, Chrousos GP. Urinary free cortisol values in normal children and adolescents. J Pediatr 1991;118:256-258.
14. Murphy BEP. Clinical evaluation of urinary cortisol determinations by competitive protein binding radioassay. J Clin Endocrinol Metab 1968;28:343-348.
15. Silber RH, Porter CC. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem 1954;210:923-932.
16. Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. J Clin Endocrinol Metab 1993;77:173-177.
17. Stratakis CA, Mastorakos G, Magiakou MA, Papavasiliou E, Oldfield EH, Chrousos GP. Thyroid function in children with Cushing's disease before and after transsphenoidal surgery. J Pediatr 1997;131:905-909.
18. Magiakou MA, Mastorakos GM, Gomez T, Rose SR, Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease. J Clin Endocrinol Metab 1994;78:131-137.
19. Magiakou MA, Mastorakos G, Chrousos GP. Final stature in patients with endogenous Cushing's syndrome. J Clin Endocrinol Metab 1994;79:1082-1085.
20. Leong GM, Mercado-Asis LB, Reynolds JC et al. Endogenous Cushing syndrome in children causes a marked decrease in bone mineral density and changes in markers of bone turnover that suggest suppression of both osteoblast and osteoclast activity. In: Programs and abstracts of the 77th Annual Meeting of the Endocrine Society, Washington, D.C., June 14-17, 1995. Bethesda, MD: Endocrine Society Press, 1995:438.
21. Michelson D, Stratakis CA, Hill L, Reynolds J, et al. Bone mineral density in women with depression. N Engl J Med 1996;335:1176-1181.
22. Arem AJ, Kirscher CW. Analysis of striae. Plast Reconstr Surg 1980;65:22-29.
23. Serres M, Viac J, Schmitt DB. Glucocorticoid receptor localization in human epidermal cells. Arch Dermatol Res 1996;288:140-146.
24. Chedid M, Hoyle JR, Csaky KG, Rubin JS. Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts. Endocrinol 1996;137:2232-2237.
25. Meisler N, Shull S, Xie R, et al. Glucocorticoids coordinately regulate type I collagen pro-alpha 1 promoter activity through both the glucocorticoid and TGF-b response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes. J Cell Biochem 1995;59:376-388.
26. Brauchle M, Fassler R, Werner S. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Invest Dermatol 1995;105: 579-584.
27. Haapasaari KM, Risteli J, Oikarinen A. Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects. J Dermatol 1996;135:65-69.
28. McMichael AJ, Griffiths CE, Talwar HS, et al. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. Br J Dermatol 1996;135:60-64.
29. Nesbitt LT Jr. Minimizing complications from systemic glucocorticoid use. Dermatol Clin 1995;13:925-939.
30. Bouzas EA, Mastorakos G, Friedman TC, Scott MH, Chrousos GP, Kaiser-Kupfer MI. Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation. Invest Ophthalmol Vis Sci 1993;34:3497-3500.